Laboratorium benaming: - UZ Leuven

SEARCH TERMSMetanefrines[A] MeSH Database (PubMed): MeSH term: “metanephrines”, “metanephrines and pheochromocytoma”,“pheochromocytoma”[B] PubMed Clinical Queries (from 1966; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi): Systematic Reviews; ClinicalQueries using Research Methodology Filters[C] UpToDate Online version 7.3 (2010)RELEVANT EVIDENCE/REFERENCES1) Guidelines and Recommendations[1] Pacak K, Eisenhofer G, Ahlman H et al. Pheochromocytoma: recommendations for clinical practice from thefirst international symposium. Nat Clin Pract Endocrinol Metab 2007; 3: 92-102.[2] American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis andtreatment of hypertension. (AACE guidelines). Endocr Pract 2006; 12: 193-222.[3] The clinical and laboratory standards institute (CLSI), GP13-P vol 7, nr 8 “Collection and preservation of timed urinespecimens”.2) Systematic Reviews and Meta-analyses[4] Sawka AM, Prebtani APH, Thabane L, Gafni A, Levine M, Young WF. A systematic review of the literatureexamining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemicaldiagnosis of pheochromocytoma. BMC Endocrine disorders 2004; 4: 2.3) Reviews[5] Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K. Update on pediatric pheochromocytoma. PediatrNephrol 2009; 24: 943-950.[6] Grossman A et al. Biochemical diagnosis and localization of pheochromocytoma. Ann NY Acac Sci 2006;1073: 332-347.[7] Cicala MV, Sartorato P, Mantero F. Incidentally discovered masses in hypertensive patients. Best Pract ResClin Endocrinol Metab 2006; 20: 451-466.[8] Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366: 665-675.[9] Kudva Yogish C, Sawka AM, Young WF. The laboratory diagnosis of adrenal pheochromocytoma: the MayoClinic experience. J Clin Endocrinol Metab 2003; 88 (10): 4533-4539.[10] Kloos RT, Gross MD. Francis IR et al. Incidentally discovered adrenal masses. Endocrine Reviews 1995; 26:460-484.[11] Krane NK. Clinically unsuspected pheochromocytomas. Experience at Henry Ford Hospital and a review ofthe literature. Arch Intern Med 1986; 146: 54-57.[12] Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma: a review of a 50-years autopsy series. Mayo Clinic Proceedings 1981; 56: 354-360.4) Original Articles[13] Mantero F, Terzolo M, Arnaldi G et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab2000; 85: 637-644.[14] Manelli M, Ianni L, Cilotti A, Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. Eur JEndocrinol 1999; 141: 619-24.[15] Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis,features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. JClin Endocrinol Metab 2005; 90: 2110-16.[16] Eisenhofer G. Free or total metanephrines for diagnosis of pheochromocytoma: what is the difference? ClinChem 2001; 47: 988-989.[17] Lenders JWM, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma which test is best?JAMA 2002; 287: 1427-1434.[18] Guller U et al. Detecting pheochromocytoma: defining the most sensitive test. Ann surg 2006; 243: 102-107.[19] Unger et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma inpatients with adrenal mass. Eur J Endocrinol 2006; 154: 409-417.[20] Gerlo EA, Sevens C. Urinary and plasma catecholamines and urinary catecholamine metabolites inpheochromocytoma: diagnostic value in 19 cases. Clin Chem 1994; 40: 250-56.[21] Raber W, Raffesberg W, Bischof M et al. Diagnostic efficacy of unconjugated plasma metanephrines for thedetection of pheochromocytoma. Arch Intern Med 2000; 160: 2957-63.[22] Gardet V, Gatta B, Simonnet G et al. Lessons from an unpleasant surprise: a biochemical strategy for thediagnosis of pheochromocytoma. J hypertens 2001; 19: 1029-35.[23] Sawka AM, Jaeschke R, Singh RJ, Young WF. A comparison of biochemical tests for pheochromocytoma:measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinarymetanephrines and catecholamines. J Clin Endocrinol Metab 2003; 88: 553-58.[24] Davidson DF. Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary freemetadrenalines. Ann Clin Biochem 2002; 39: 557-66.pagina 4/29